#VisualAbstract: Neoadjuvant HD201 shows similar efficacy to referent trastuzumab for ERBB2-positive breast cancer
Click to read this study in JAMA Oncology.
Tag: Herceptin
#VisualAbstract: Pertuzumab plus trastuzumab significantly improves survival in metastatic breast cancer
Click to read this study in JAMA Network Open.
Trastuzumab associated with increased reversible cardiac changes
Image: PD 1. At 8 years median follow-up, trastuzumab treatment for HER2-positive breast cancer is associated with slightly increased rates ...
One-year of Herceptin preferable to two-year regimen
Image: PD 1. One year of adjuvant Herceptin (trastuzumab) has similar efficacy as a two-year regimen. 2. One-year regimen was ...
